Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality

Addiction Medicine: Beyond the Abstract

American Society of Addiction Medicine द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री American Society of Addiction Medicine या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।

3M ago 20:04

MP3•एपिसोड होम

Host Shawn McNeil, MD, is joined by Michelle Lofwall, MD, DFAPA, DFASAM, a professor in the Department of Behavioral Science and Psychiatry at the University of Kentucky and Medical Director of UK’s Robert Straus and First Bridge Clinics, which provide comprehensive OUD treatment within the UK Center on Drug and Alcohol Research. Dr. Lofwall and her co-authors examined the relationship between the dose in the early stages of treatment and the subsequent risk of death and found some surprising results.

Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality

Journal of Addiction Medicine 18(3):p 319-326, 5/6 2024

May-June 2024

35 एपिसोडस

#Science #Shawn McNeil #Shawn McNeil MD